2026-03093Notice

FDA's AI Drug Watch: Comment on Safety Tech Revolution

Published Date: 2/18/2026

Notice

Summary

The FDA is asking for public feedback on a new plan to use smart technology like AI to better track drug safety after medicines hit the market. This affects drug companies who must report safety info and could speed up how quickly problems are spotted. Comments are open until March 20, 2026, so now’s the time to weigh in on this tech upgrade that aims to keep medicines safer and reporting smoother.

Analyzed Economic Effects

3 provisions identified: 1 benefits, 1 costs, 1 mixed.

Industry Meeting Burden: 10–30 Hours

If your organization wants to present to FDA under the Emerging Drug Safety Technology Program, you must prepare an initial meeting proposal (about 10 hours). If selected, you must prepare and deliver a 20–50 minute presentation, which FDA estimates will take about 30 hours. FDA estimates 25 organizations will request presentations per year, about 12 meetings will be held per year, and the total annual burden across respondents is 610 hours.

Faster Drug Safety Detection

The FDA says using AI and other emerging technologies in postmarket pharmacovigilance could create more efficiencies and help spot safety problems sooner. The Emerging Drug Safety Technology Program is meant to accelerate FDA's understanding of these tools so problems with medicines may be identified more quickly.

May Shape Future AI Drug Rules

FDA will use information from Emerging Drug Safety Technology meetings to inform potential regulatory and policy approaches for AI and other emerging technologies in postmarket safety surveillance. If your organization develops or uses AI for pharmacovigilance, what you share could influence future FDA policies.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
2/18/2026
3/20/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in